ReviewIranian journal of public health2019
Epidemiology and Risk Factors of Alzheimer's Disease in Iran: A Systematic Review.
Review in Iranian journal of public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 29 citations in OpenAlex.
- Pooled it
- Diagnostic accuracy of cognitive screening tools validated for older adults in Iran: a systematic review and meta-analysis.BMC geriatrics · 2024Pooled it
- Uncovering the extent of dementia prevalence in Iran: a comprehensive systematic review and meta-analysis.BMC public health · 2024Pooled it
- Feasibility, safety, and adherence of a remote physical and cognitive exercise protocol for older women.Arquivos de neuro-psiquiatria · 2024Trial
- Retinal sublayer changes in cases with Alzheimer's disease and depression.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Feasibility of identifying factors related to Alzheimer's disease and related dementia in real-world data.JAMIA open · 2026Review
- Prevalence and influencing factors of dementia in the elderly iranian population: a cross-sectional study.Aging clinical and experimental research · 2025Article
- Article
- Association between the DASH diet and Alzheimer's disease in a case-control study.Scientific reports · 2025Article
- Short-term Efficacy of Commercial Curcumin Nanomicelle on Cognition, Oxidative Stress and Choline Esterase in Alzheimer's Disease.Basic and clinical neuroscience · 2025Article
- Scientometric insights into neurology publications in Iran.Current journal of neurology · 2025Article
- When Stroke Disguises as Dementia: A Case of Missed Cerebral Venous Thrombosis.Clinical case reports · 2025Article
- Article
- Dementia prevalence among hospitalized older patients: a multicenter study in Iran.Dementia & neuropsychologia · 2024Article
- Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment Using Convolutional Neural Networks.Journal of Alzheimer's disease reports · 2024Article
- The Association between Levels of Physical Activity and Lifestyle, Life Expectancy, and Quality of Life in Patients with Alzheimer's Disease.Journal of clinical medicine · 2023Article
- The association of arsenic exposure with mortality due to cancer, diabetes, Alzheimer's and congenital anomalies using Poisson regression.Scientific reports · 2023Article
- Temporal Trends in Mortality from Alzheimer's Disease in Federal District, Brazil: An Ecological Study (2010-2018).International journal of environmental research and public health · 2023Article
- Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint.Life (Basel, Switzerland) · 2022Review
- Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden.Frontiers in neurology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlzheimer's disease is a chronic disease characterized by a progressive decline in mental abilities and quality of life alongside behavioral abnormalities associated with high economic burden. The purpose of this study was to investigate epidemiology and risk factors of Alzheimer's disease in Iran.
methodsIn this systematic review study, both Persian and English-language databases including Medline, Google Scholar, PubMed, web of science and Magiran were searched using following keywords: epidemiology, Alzheimer, dementia and Iran without time limit up to 2017. Thirty articles abstract out of 50 studies related to this topics, were reviewed. Of which 12 full text entered into the quality assessment process and finally, four articles were selected for inclusion in this study and their results was extracted.
resultsThe total sample size of the 4 selected studies was 2781. The prevalence of Alzheimer's disease in the current study was estimated to be 2.3% in the population of 67-78 years old. Age, genetics, depression and hypertension were determined as the risk factors for Alzheimer's disease, while daily listening to music, meeting weekly with friends and daily intake of vitamin E were considered as the factors with protective role in this disease.
conclusionAlzheimer's disease is one of the main causes of functional dependence and mortality in the elderly people. Lifestyle changes and multiple mental activities in elderly increases the cognitive ability of these population, which will reduce direct and indirect costs of this disease.
Indexed as
Identifiers
31993381PMC6974866W2995138811What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.